- You can view the full Bristol-Myers Squibb Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Jim Cramer says results can look better when you're expecting the worst.
Stock losses escalated in the final hour as an increase in Treasury yields hit defensive names in the utilities and materials sectors.
Posting results 'not as a bad as we thought' has become a successful strategy. It worked for Bristol.
Stock losses accelerate heading into the market close on Thursday after defensive names slip on a spike in Treasury yields.